Loading...
Loading...
Comprehensive profiles of research-grade peptides including BPC-157, TB-500, GHK-Cu, and more. Detailed dosing, protocols, and safety information for serious optimizers.
May support reductions in fat mass while preserving lean muscle in animal models.
Benefits: Enhanced cognitive function, neuroprotection, mood support, and increased neuroplasticity.
Notable targeted fat mass reduction (up to 30% body weight in rodents, ~11% in primates over 4 weeks).
Endurance Enhancement: Sedentary mice treated with AICAR showed a +44% increase in endurance without training.
Neuroprotection: Improvements reported in clinical trials for diabetic neuropathy.
Weight reduction: Cagrilintide 4.5 mg weekly produced approximately 10.8% body weight loss over 26 weeks versus 3.0% with placebo.
May support fibroblast proliferation and reduce markers of cellular senescence in aged cell cultures.
May support bronchopulmonary tissue function and respiratory cell regulation based on bioregulator peptide research.
Sustained elevation of GH and IGF-1 levels over extended periods with once-daily or even less frequent dosing.
Sustained elevation of GH and IGF-1 levels supporting muscle growth, recovery, and lean body composition.
Body composition improvements in lean mass and reductions in fat mass.
Stimulates pulsatile GH release and elevates IGF‑1 levels with chronic administration.
Supports sustained GH and IGF-1 elevation through pulsatile release patterns.
Supports peripheral nerve regeneration with improved growth rate and conduction velocity in injury models.
Promotes selective clearance of senescent cells in various tissues.
Potent stimulation of endogenous GH release without suppressing natural production.
Muscle Growth & Fat Loss: Elevated GH and IGF-1 levels support increased lean body mass and reduced fat mass over time.
Accelerated Wound Healing: All three components have shown the ability to speed up the repair of injuries.
Supports reduction of oxidative stress markers and maintenance of cellular redox balance.
Supports endogenous testosterone production by stimulating LH release.
Fertility Preservation: Maintains testosterone and spermatogenesis during TRT.
Potential Benefits: Increases in lean body mass, reductions in adipose tissue, improved metabolic parameters.
Potential Benefits: Stimulates spermatogenesis, improves sperm parameters, increases pregnancy rates, supports testicular function.
Enhanced anabolic signaling and protein synthesis.
Potential Benefits: Accelerated tissue repair, reduced inflammation, enhanced collagen synthesis, promotion of angiogenesis.
Enhanced fat metabolism: Facilitates mitochondrial fatty acid oxidation and ATP production from lipid stores.
Supports inhibition of enkephalin-degrading enzymes, potentially prolonging endogenous enkephalin signaling.
Potential Benefits:
Promotes satellite cell activation and myoblast proliferation in muscle tissue.
Improved neurological outcomes and functional recovery following stroke or brain injury.
May support gastrointestinal and hepatic tissue bioregulation based on ultrashort peptide bioregulator research.
Rapid Antidepressant Effects: Produces behavioral improvements within 4 days in rodent models; reduces immobility in forced swim tests and decreases latency to feed in novel environments.
Animal studies demonstrate enhanced muscle, bone, and cartilage regeneration with MGF analogues administered over multiple weeks.
Neuroprotective effects through reduction of oxidative stress and preservation of neuronal viability.
Preclinical studies suggest selective cytotoxicity toward cancer cells expressing abnormal p53/HDM-2 while sparing normal cells.
Reduced inflammation in rat prostatitis models.
Enhanced mitochondrial function.
Reduces wrinkle depth by an average of approximately 35%, with maximal improvements approaching 60%.
Dose-dependent weight loss of 12.5–14.9% (vs placebo) over 46 weeks in phase 2 obesity trials.
Preclinical studies suggest normalization of thyroid hormone parameters in hypophysectomized models.
TB-500: Promotes cell proliferation, angiogenesis, and accelerated tissue repair; inhibits apoptosis and inflammation.
May support vascular endothelial cell proliferation and renewal through Ki-67 gene regulation.
Supports immune cell marker expression (CD5+ lymphocytes) and IL‑2 gene activity in cell culture models.
A 15-amino-acid peptide derived from human gastric juice with potent tissue-healing and anti-inflammatory properties.
A synthetic version of Thymosin Beta-4 that promotes tissue repair, reduces inflammation, and supports recovery from injuries.
An FDA-approved GLP-1 receptor agonist originally developed for type 2 diabetes, now widely used for weight management and metabolic optimization.
A dual GIP/GLP-1 receptor agonist that has shown superior weight loss and metabolic outcomes compared to semaglutide in head-to-head trials.
A pre-mixed blend combining BPC-157 and TB-500 for comprehensive tissue repair, combining local and systemic healing mechanisms.
A pre-mixed growth hormone secretagogue blend combining CJC-1295 (no DAC) with Ipamorelin for optimized pulsatile GH release.
A modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis and fat oxidation without the growth-promoting or diabetogenic effects of full GH.
The first FDA-approved GHRH analog for GH deficiency testing, now widely used off-label as a growth hormone secretagogue with the longest clinical safety record of any GH peptide.
The copper-free form of the GHK tripeptide with skin rejuvenation and wound healing properties — available in topical formulations for cosmetic and dermatological applications.
An orally active growth hormone secretagogue that mimics ghrelin signaling — the only non-injectable GH-releasing compound, providing 24-hour IGF-1 elevation from a single daily dose.